Unraveling the Role of GPX4 Pathway in Ferroptosis and its Implications for Gastric Cancer Management

Mengran Zhao; Junxuan Xu; Shengquan Zhu; Peng Li*

Mengran Zhao, Junxuan Xu, Shengquan Zhu and Peng Li*

Volume4-Issue12
Dates: Received: 2023-12-13 | Accepted: 2023-12-26 | Published: 2023-12-27
Pages: 1692-1696

Abstract

Gastric Cancer (GC) presents a significant global health concern due to its high incidence and mortality rates. Despite advancements in medical treatments, drug resistance poses a major challenge in managing GC. Ferroptosis, a form of programmed cell death driven by iron-dependent lipid peroxidation, has emerged as a key contributor to treatment resistance in GC. The pivotal role of GPX4, a regulator of ferroptosis, has garnered considerable attention in cancer research. GPX4 synthesis and expression are subject to regulation at multiple levels, including transcription, translation, and posttranslational modifications. Ongoing development of pharmacological therapeutics targeting GPX4 aims to induce ferroptosis in cancer cells. This review provides an overview of the GPX4 pathway’s involvement in GC, shedding light on the implications of ferroptosis induction in combatting cancer resilience. These findings emphasize the therapeutic potential of GPX4 in managing gastric cancer and other malignancies, presenting novel opportunities to address the challenges of treatment resistance.

FullText HTML FullText PDF DOI: 10.37871/jbres1854

Certificate of Publication

Copyright

How to cite this article

Zhao M, Xu J, Zhu S, Li P. Unraveling the Role of GPX4 Pathway in Ferroptosis and its Implications for Gastric Cancer Management. J Biomed Res Environ Sci. 2023 Dec 27; 4(12): 1692-1696. doi: 10.37871/jbres1854, Article ID: JBRES1854, Available at: https://www.jelsciences.com/articles/jbres1854.pdf

Subject area(s)

Oncology

Cancer

References

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
Zheng RS, Zhang SW, Sun KX, Chen R, Wang SM, Li L, Zeng HM, Wei WW, He J. [Cancer statistics in China, 2016]. Zhonghua Zhong Liu Za Zhi. 2023 Mar 23;45(3):212-220. Chinese. doi: 10.3760/cma.j.cn112152-20220922-00647. PMID: 36944542.
Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS. Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study. Gastroenterology. 2020 Feb;158(3):527-536.e7. doi: 10.1053/j.gastro.2019.10.019. Epub 2019 Oct 22. PMID: 31654635; PMCID: PMC7010558.
Ajani JA, Abramov M, Bondarenko I, Shparyk Y, Gorbunova V, Hontsa A, Otchenash N, Alsina M, Lazarev S, Feliu J, Elme A, Esko V, Abdalla K, Verma U, Benedetti F, Aoyama T, Mizuguchi H, Makris L, Rosati G; DIGEST Study Group. A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer. Ann Oncol. 2017 Sep 1;28(9):2142-2148. doi: 10.1093/annonc/mdx275. PMID: 28911091.
Kang YK, Chin K, Chung HC, Kadowaki S, Oh SC, Nakayama N, Lee KW, Hara H, Chung IJ, Tsuda M, Park SH, Hosaka H, Hironaka S, Miyata Y, Ryu MH, Baba H, Hyodo I, Bang YJ, Boku N. S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial. Lancet Oncol. 2020 Aug;21(8):1045-1056. doi: 10.1016/S1470-2045(20)30315-6. Epub 2020 Jul 16. PMID: 32682457.
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012 May 25;149(5):1060-72. doi: 10.1016/j.cell.2012.03.042. PMID: 22632970; PMCID: PMC3367386.
Wang F, Chen C, Chen WP, Li ZL, Cheng H. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer. Biomed Res Int. 2021 Oct 18;2021:6014202. doi: 10.1155/2021/6014202. PMID: 34708125; PMCID: PMC8545527.
Xu X, Zhou N, Lan H, Yang F, Dong B, Zhang X. The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer. Int J Mol Sci. 2022 Aug 29;23(17):9767. doi: 10.3390/ijms23179767. PMID: 36077165; PMCID: PMC9456108.
Ma J, Hu X, Yao Y, Wu L, Sheng C, Chen K, Liu B. Characterization of Two Ferroptosis Subtypes With Distinct Immune Infiltration and Gender Difference in Gastric Cancer. Front Nutr. 2021 Dec 16;8:756193. doi: 10.3389/fnut.2021.756193. PMID: 34977116; PMCID: PMC8716917.
Shao Y, Jia H, Li S, Huang L, Aikemu B, Yang G, Zhang S, Sun J, Zheng M. Comprehensive Analysis of Ferroptosis-Related Markers for the Clinical and Biological Value in Gastric Cancer. Oxid Med Cell Longev. 2021 Oct 27;2021:7007933. doi: 10.1155/2021/7007933. PMID: 34745421; PMCID: PMC8566081.
Li J, Xiang R, Song W, Wu J, Kong C, Fu T. A Novel Ferroptosis-Related LncRNA Pair Prognostic Signature Predicts Immune Landscapes and Treatment Responses for Gastric Cancer Patients. Front Genet. 2022 Jun 20;13:899419. doi: 10.3389/fgene.2022.899419. Erratum in: Front Genet. 2022 Oct 18;13:1028480. PMID: 35795206; PMCID: PMC9250987.
Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, Brown LM, Girotti AW, Cornish VW, Schreiber SL, Stockwell BR. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014 Jan 16;156(1-2):317-331. doi: 10.1016/j.cell.2013.12.010. PMID: 24439385; PMCID: PMC4076414.
Ursini F, Maiorino M, Valente M, Ferri L, Gregolin C. Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim Biophys Acta. 1982 Feb 15;710(2):197-211. doi: 10.1016/0005-2760(82)90150-3. PMID: 7066358.
Weaver K, Skouta R. The Selenoprotein Glutathione Peroxidase 4: From Molecular Mechanisms to Novel Therapeutic Opportunities. Biomedicines. 2022 Apr 13;10(4):891. doi: 10.3390/biomedicines10040891. PMID: 35453641; PMCID: PMC9027222.
Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, Kaffenberger SD, Eaton JK, Shimada K, Aguirre AJ, Viswanathan SR, Chattopadhyay S, Tamayo P, Yang WS, Rees MG, Chen S, Boskovic ZV, Javaid S, Huang C, Wu X, Tseng YY, Roider EM, Gao D, Cleary JM, Wolpin BM, Mesirov JP, Haber DA, Engelman JA, Boehm JS, Kotz JD, Hon CS, Chen Y, Hahn WC, Levesque MP, Doench JG, Berens ME, Shamji AF, Clemons PA, Stockwell BR, Schreiber SL. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017 Jul 27;547(7664):453-457. doi: 10.1038/nature23007. Epub 2017 Jul 5. PMID: 28678785; PMCID: PMC5667900.
Liu H, Schreiber SL, Stockwell BR. Targeting Dependency on the GPX4 Lipid Peroxide Repair Pathway for Cancer Therapy. Biochemistry. 2018 Apr 10;57(14):2059-2060. doi: 10.1021/acs.biochem.8b00307. Epub 2018 Mar 27. PMID: 29584411; PMCID: PMC5962875.
Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, Kaffenberger SD, Eaton JK, Shimada K, Aguirre AJ, Viswanathan SR, Chattopadhyay S, Tamayo P, Yang WS, Rees MG, Chen S, Boskovic ZV, Javaid S, Huang C, Wu X, Tseng YY, Roider EM, Gao D, Cleary JM, Wolpin BM, Mesirov JP, Haber DA, Engelman JA, Boehm JS, Kotz JD, Hon CS, Chen Y, Hahn WC, Levesque MP, Doench JG, Berens ME, Shamji AF, Clemons PA, Stockwell BR, Schreiber SL. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017 Jul 27;547(7664):453-457. doi: 10.1038/nature23007. Epub 2017 Jul 5. PMID: 28678785; PMCID: PMC5667900.
Guerriero E, Capone F, Accardo M, Sorice A, Costantini M, Colonna G, Castello G, Costantini S. GPX4 and GPX7 over-expression in human hepatocellular carcinoma tissues. Eur J Histochem. 2015 Dec 1;59(4):2540. doi: 10.4081/ejh.2015.2540. PMID: 26708178; PMCID: PMC4698610.
Yagublu V, Arthur JR, Babayeva SN, Nicol F, Post S, Keese M. Expression of selenium-containing proteins in human colon carcinoma tissue. Anticancer Res. 2011 Sep;31(9):2693-8. PMID: 21868509.
Rudenko E, Kondratov O, Gerashchenko G, Lapska Y, Kravchenko S, Koliada O, Vozianov S, Zgonnyk Y, Kashuba V. Aberrant expression of selenium-containing glutathione peroxidases in clear cell renal cell carcinomas. Exp Oncol. 2015 Jun;37(2):105-10. PMID: 26112936.
Kinowaki Y, Kurata M, Ishibashi S, Ikeda M, Tatsuzawa A, Yamamoto M, Miura O, Kitagawa M, Yamamoto K. Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma. Lab Invest. 2018 May;98(5):609-619. doi: 10.1038/s41374-017-0008-1. Epub 2018 Feb 20. PMID: 29463878.
Sugezawa K, Morimoto M, Yamamoto M, Matsumi Y, Nakayama Y, Hara K, Uejima C, Kihara K, Matsunaga T, Tokuyasu N, Sakamoto T, Umekita Y, Fujiwara Y. GPX4 Regulates Tumor Cell Proliferation via Suppressing Ferroptosis and Exhibits Prognostic Significance in Gastric Cancer. Anticancer Res. 2022 Dec;42(12):5719-5729. doi: 10.21873/anticanres.16079. PMID: 36456115.
Wang Y, et al. Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer. Cell Death Differ. 2022;29(11): p. 2190-2202. doi: 10.1038/s41418-022-01008-w.
Li D, Wang Y, Dong C, Chen T, Dong A, Ren J, Li W, Shu G, Yang J, Shen W, Qin L, Hu L, Zhou J. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene. 2023 Jan;42(2):83-98. doi: 10.1038/s41388-022-02537-x. Epub 2022 Nov 12. PMID: 36369321; PMCID: PMC9816059.
Wang T, Zhou Z, Wang C, Qin Y, Wu L, Hu B, Jin Q, Wei W, Huang M. LTBP2 Knockdown Promotes Ferroptosis in Gastric Cancer Cells through p62-Keap1-Nrf2 Pathway. Biomed Res Int. 2022 Aug 4;2022:6532253. doi: 10.1155/2022/6532253. PMID: 35968244; PMCID: PMC9371865.
Wang H, Breadner DA, Deng K, Niu J. CircRHOT1 restricts gastric cancer cell ferroptosis by epigenetically regulating GPX4. J Gastrointest Oncol. 2023 Aug 31;14(4):1715-1725. doi: 10.21037/jgo-23-550. Epub 2023 Aug 30. PMID: 37720433; PMCID: PMC10502555.
Ouyang S, Li H, Lou L, Huang Q, Zhang Z, Mo J, Li M, Lu J, Zhu K, Chu Y, Ding W, Zhu J, Lin Z, Zhong L, Wang J, Yue P, Turkson J, Liu P, Wang Y, Zhang X. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biol. 2022 Jun;52:102317. doi: 10.1016/j.redox.2022.102317. Epub 2022 Apr 21. PMID: 35483272; PMCID: PMC9108091.
Li R, Yin B, Zeng D, Liu Z. A novobiocin derivative, XN4, triggers ferroptosis in gastric cancer cells via the activation of NOX4. Pharm Biol. 2022 Dec;60(1):1449-1457. doi: 10.1080/13880209.2022.2099431. PMID: 35938505; PMCID: PMC9361764.
Zhang J, Gao M, Niu Y, Sun J. From DNMT1 degrader to ferroptosis promoter: Drug repositioning of 6-Thioguanine as a ferroptosis inducer in gastric cancer. Biochem Biophys Res Commun. 2022 May 7;603:75-81. doi: 10.1016/j.bbrc.2022.03.026. Epub 2022 Mar 6. PMID: 35278883.
Ni Z, Nie X, Zhang H, Wang L, Geng Z, Du X, Qian H, Liu W, Liu T. Atranorin driven by nano materials SPION lead to ferroptosis of gastric cancer stem cells by weakening the mRNA 5-hydroxymethylcytidine modification of the Xc-/GPX4 axis and its expression. Int J Med Sci. 2022 Sep 25;19(11):1680-1694. doi: 10.7150/ijms.73701. PMID: 36237989; PMCID: PMC9553860.
Mi XJ, Park HR, Dhandapani S, Lee S, Kim YJ. Biologically synthesis of gold nanoparticles using Cirsium japonicum var. maackii extract and the study of anti-cancer properties on AGS gastric cancer cells. Int J Biol Sci. 2022 Sep 21;18(15):5809-5826. doi: 10.7150/ijbs.77734. PMID: 36263176; PMCID: PMC9576503.
Liu Y, Song Z, Liu Y, Ma X, Wang W, Ke Y, Xu Y, Yu D, Liu H. Identification of ferroptosis as a novel mechanism for antitumor activity of natural product derivative a2 in gastric cancer. Acta Pharm Sin B. 2021 Jun;11(6):1513-1525. doi: 10.1016/j.apsb.2021.05.006. Epub 2021 May 13. PMID: 34221865; PMCID: PMC8245858.
Zhao L, Peng Y, He S, Li R, Wang Z, Huang J, Lei X, Li G, Ma Q. Apatinib induced ferroptosis by lipid peroxidation in gastric cancer. Gastric Cancer. 2021 May;24(3):642-654. doi: 10.1007/s10120-021-01159-8. Epub 2021 Feb 5. PMID: 33544270.
Zhang L, Li C, Zhang Y, Zhang J, Yang X. Ophiopogonin B induces gastric cancer cell death by blocking the GPX4/xCT-dependent ferroptosis pathway. Oncol Lett. 2022 Mar;23(3):104. doi: 10.3892/ol.2022.13224. Epub 2022 Feb 1. PMID: 35154435; PMCID: PMC8822489.